No Data
【Brokerage Focus】Zhongtai International: Hong Kong stocks are adjusting at a high level, and the Federal Reserve is slowing its balance sheet reduction.
Jinwu Financial News | On March 21, Zhongtai International's morning report stated that on March 20, the Hong Kong stock market's Large Cap experienced a high-level adjustment, with the Hang Seng Index opening at its highest point of the day, followed by a continuous decline, eventually dropping by 551 points or 2.2%, closing at 24,219 points; the Hang Seng Tech Index fell by 3.4%, closing at 5,836 points. The overall market transaction amount increased to over 294.9 billion HKD, with a net Outflow of 0.407 billion HKD from the Hong Kong Stock Connect. In terms of market performance, Hong Kong stocks faced widespread declines, with thematic stocks, heavyweights, and high-performing stocks all falling, while only a few stocks in oil, Biomedical, Marine Transportation, utilities, and Autos went against the trend and rose.
REMEGEN (09995.HK) will release its Earnings Reports on March 27.
$REMEGEN (09995.HK) will release its Earnings Reports on March 27, and investors are advised to pay attention. Futubull Reminder: 1. There is no strict regulation on the accounting fiscal year for companies listed on the Hong Kong and US stock markets, and it is entirely decided by the enterprises themselves; thus, each Earnings Reports period can be treated as the company's annual report cut-off date, instead of adhering to the natural calendar year for the fiscal year. 2. Generally, the company will hold an Earnings Reports meeting on or around the published date, during which the management will discuss and explain the latest quarterly Earnings Reports data and operational status, and communicate with investors, Analysts, media, etc.
RemeGen to Present Results of Phase 3 Study for Generalized Myasthenia Gravis Drug
RemeGen's Telitacicept Study Gains Spotlight at 2025 AAN Meeting
REMEGEN (09995.HK) plans to hold a Board of Directors meeting on March 27 to approve the annual performance.
Gelonghui reported on March 17 that REMEGEN (09995.HK) announced that the Board of Directors will hold a meeting on Thursday, March 27, 2025, to consider and approve the annual performance of the company and its subsidiaries for the year ending December 31, 2024, and its publication, as well as to consider matters related to dividends (if any).
REMEGEN: DATE OF BOARD MEETING
RemeGen Co., Ltd.'s (HKG:9995) Shares Climb 29% But Its Business Is Yet to Catch Up
